Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma
- PMID: 16639623
- DOI: 10.1007/s00417-006-0321-7
Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma
Abstract
Background: Treatment of neovascular glaucoma (NVG) must be focused on the reduction of intraocular pressure (IOP) and prompt application of pan retinal photocoagulation (PRP). A combination of complete PRP during vitrectomy with trabeculectomy should theoretically be a better method to lower the IOP rapidly in eyes with NVG. The purpose of our study is to assess the efficacy of combining pars plana vitrectomy and PRP with trabeculectomy assisted by mitomycin C (MMC) on NVG eyes secondary to diabetic retinopathy.
Methods: Twenty-five eyes with NVG associated with diabetic retinopathy had pars plana vitrectomy, followed by PRP and trabeculectomy with MMC. The eyes were divided into two groups: nine eyes with vitreous hemorrhage, fibrovascular membrane and/ or retinal detachment were placed in the Proliferation group; and 16 eyes without vitreous hemorrhage, fibrovascular membrane, or retinal detachment were placed in the PC (photocoagulation) group. These eyes had vitrectomy performed so that PRP could be safely performed from ora to ora. The surgical outcome in the two groups was assessed by Kaplan-Meier survival analysis. The criteria for success were a postoperative intraocular pressure (IOP) < or =21 mmHg and a preservation of light perception.
Results: In the Proliferation group, Kaplan-Meier life-table analysis showed that the success rate was 55.6% after 1 year and 18.5% after 2 years. The success rate in the PC group was 81.2% from 1 to 3 years after surgery. The surgical outcome was significantly better in the PC group than in the Proliferation group (P=0.009). In the Proliferation group, four eyes had preoperative vitreous hemorrhage, three eyes had a fibrovascular membrane, and two eyes had a retinal detachment. Three of four eyes with vitreous hemorrhage achieved good IOP control. On the other hand, the IOP of all eyes with retinal detachment and fibrovascular membrane were not lowered significantly.
Conclusions: Complete PRP combined with trabeculectomy with MMC can effectively reduce the elevated IOP in eyes with NVG. However, this combined treatment is not effective in eyes with proliferative membranes and retinal detachments.
Similar articles
-
Full preoperative panretinal photocoagulation improves the outcome of trabeculectomy with mitomycin C for neovascular glaucoma.Eur J Ophthalmol. 2008 Sep-Oct;18(5):758-64. doi: 10.1177/112067210801800516. Eur J Ophthalmol. 2008. PMID: 18850555
-
Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients.Ophthalmologica. 2006;220(6):383-8. doi: 10.1159/000095865. Ophthalmologica. 2006. PMID: 17095884
-
Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy.BMC Ophthalmol. 2025 Mar 28;25(1):159. doi: 10.1186/s12886-025-03984-2. BMC Ophthalmol. 2025. PMID: 40155830 Free PMC article.
-
A review of neovascular glaucoma. Etiopathogenesis and treatment.Rom J Ophthalmol. 2021 Oct-Dec;65(4):315-329. doi: 10.22336/rjo.2021.66. Rom J Ophthalmol. 2021. PMID: 35087972 Free PMC article. Review.
-
Management of proliferative diabetic retinopathy.Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.
Cited by
-
Anti-vascular endothelial growth factor for neovascular glaucoma.Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4. Cochrane Database Syst Rev. 2023. PMID: 37010901 Free PMC article.
-
A new manner of reporting pressure results after glaucoma surgery.Clin Ophthalmol. 2012;6:23-31. doi: 10.2147/OPTH.S13674. Epub 2011 Dec 30. Clin Ophthalmol. 2012. PMID: 22259232 Free PMC article.
-
Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1601-9. doi: 10.1007/s00417-010-1406-x. Epub 2010 Jun 4. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20524132
-
Neovascular glaucoma.Prog Retin Eye Res. 2007 Sep;26(5):470-85. doi: 10.1016/j.preteyeres.2007.06.001. Epub 2007 Aug 8. Prog Retin Eye Res. 2007. PMID: 17690002 Free PMC article. Review.
-
Anti-vascular endothelial growth factor for neovascular glaucoma.Cochrane Database Syst Rev. 2013 Oct 2;10(10):CD007920. doi: 10.1002/14651858.CD007920.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2020 Feb 6;2:CD007920. doi: 10.1002/14651858.CD007920.pub3. PMID: 24089293 Free PMC article. Updated.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous